Triple
T2523541
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | CB1 receptor |
E55578
|
entity |
| Predicate | antagonist |
P4675
|
FINISHED |
| Object |
rimonabant
Rimonabant is a selective cannabinoid CB1 receptor antagonist that was developed as an anti-obesity drug but withdrawn due to psychiatric side effects.
|
E275982
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69ab49e4749c8190813311efd1630f1b |
elicitation | completed |
| NER | batch_69abd23a0a548190b44393e0f823f7a9 |
ner | completed |
| NED1 | batch_69af2ba96a0c819091efd6d4ccf95ea5 |
ned_source_triple | completed |
| NED2 | batch_69af5155f85081908dd4a1859d0f7907 |
ned_description | completed |
| NEDg | batch_69af508c28f48190afc4aa1bc3c9adf3 |
nedg | completed |
Created at: March 6, 2026, 9:46 p.m.